explore -WSS

explore

author：comprehensive 2025-09-30 01:02:17 - browse：669

A clipboard with checklist on blue dark background. -- health tech coverage from STAT — Adobe

A Pittsburgh artificial intelligence startup emerging as a challenger to Microsoft’s clinical note taking business has raised $150 million, a rare mega deal in a funding lull. The startup, Abridge, also has an unlikely cheerleader: Paul Ricci, the former head of Nuance, the service from Microsoft it competes with.

Abridge sells an AI tool that rapidly transcribes and summarizes doctors’ conversations with patients in a hospital’s electronic health records software. The startup’s leaders and investors tell STAT they’re betting that their medical knowledge, agility, and willingness to co-develop features with customers makes it a more attractive long term option than Nuance, which Microsoft says is currently used by most U.S. hospitals.

Microsoft, Abridge and other startups like Suki, Corti and Nabla are locked in a race to ease provider burnout by automating clinical note taking, and — thanks to generative AI — organizing the data in a way that could improve care, such as suggesting topics for follow-up, simplifying billing or analyzing trends at the broader patient population level.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Dobbs anniversary: the lost opportunity of abortion as health care
Next article： Devoted Health’s losses in Medicare Advantage persist

WSS

Police still searching for prisoner who escaped from NYC hospital

Devoted Health’s losses in Medicare Advantage persist

What to know about Virgin Galactic's 1st mission taking paying customers to space

Johnson & Johnson sued for allegedly overpaying for workers' drugs

AI gets buy

Why CTE doesn’t keep Americans from enjoying the Super Bowl

leisure time

explore

leisure time

Apple is now the first public company to be valued at $3 trillion

Amylyx's ALS drug launch starts strong. It could be trouble for FDA

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Readout LOUD: Venture capital, Gilead, and more M&A

Guidelines to prevent youth baseball injuries need more muscle

How to use technology to prevent future drug shortages

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

For Cytokinetics, FDA rejection of heart drug would help, not hinder

At least 13 dead in Texas as scorching temps continue

Surgery pushed Ben Carson to fame

explore

The best solution to the drug shortages problem

Wayne Brady comes out as pansexual: 'Free to love whomever I want'

American woman, child freed after being kidnapped in Haiti last month

Gene therapy for Afghan refugees’ infant will be fully covered

Unique patient identifier: Experts argue the benefits, pitfalls

NIH trials fail to test meaningful long Covid therapies, experts say

entertainment

focus

leisure time

focus